Axcella Health Inc. Common Stock
AXLA
AXLA was delisted on the 22nd of November, 2023.
28 hedge funds and large institutions have $132M invested in Axcella Health Inc. Common Stock in 2019 Q2 according to their latest regulatory filings, with 28 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
FP
Flagship Pioneering
Cambridge,
Massachusetts
|
+$111M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$42.8M |
| 3 |
HP
Harbourvest Partners
Boston,
Massachusetts
|
+$15.6M |
| 4 |
AG
Artal Group
Luxembourg
|
+$4.94M |
| 5 |
HM
HealthCor Management
New York
|
+$2.16M |
Top Sellers
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
JP Morgan Chase
New York
| $4K | +$5.7K | +18 | New |
|
|
AIP
27
Ameritas Investment Partners
Lincoln,
Nebraska
| $1K | +$1.9K | +6 | New |
|
28
BNP Paribas Financial Markets
Paris,
France
| $74 | – | – | – |
|
29
Wells Fargo
San Francisco,
California
| – | +$317 | +1 | New |
|
AXLA Hedge Fund Activity: Q2 2019 in Review
28 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Axcella Health Inc. Common Stock (AXLA) for Q2 2019, worth a combined $132M.
Buyers outnumbered sellers: 28 funds opened new AXLA positions and 0 closed out — a net gain of 28 holders — while 0 added to existing stakes and 0 trimmed.
The largest buyer was Flagship Pioneering, opening a new position worth an estimated $111M.
- 28 institutional investors held Axcella Health Inc. Common Stock (AXLA) as of Q2 2019, up from 0 in Q1 2019.
- Funds reported $132M of Axcella Health Inc. Common Stock stock for Q2 2019.
- 28 funds opened new Axcella Health Inc. Common Stock positions in Q2 2019 and 0 closed out, a net change of +28 holders.
- The largest Axcella Health Inc. Common Stock buyer in Q2 2019 was Flagship Pioneering, an estimated $111M added.
Based on aggregated 13F filings for Q2 2019.